Literature DB >> 24039121

Pitfalls of using administrative data sets to describe clinical outcomes in sickle cell disease.

Susan Claster1, Amanda Termuhlen, Sheree M Schrager, Julie A Wolfson, Ellen Iverson.   

Abstract

BACKGROUND: Administrative data sets are increasingly being used to describe clinical care in sickle cell disease (SCD). We recently used such an administrative database to look at the frequency of acute chest syndrome (ACS) and the use of transfusion to treat this syndrome in California patients from 2005 to 2010. Our results revealed a surprisingly low rate of transfusion for this life-threatening situation. PROCEDURE: To validate these results, we compared California OSPHD (Office of Statewide Health Planning and Development) administrative data with medical record review of patients diagnosed with ACS identified by two pediatric and one adult hospital databases during 2009-2010.
RESULTS: ACS or a related pulmonary process accounted for one-fifth of the inpatient hospital discharges associated with the diagnosis of SCD between 2005 and 2010. Only 47% of those discharges were associated with a transfusion. However, chart reviews found that hospital databases over-reported visits for ACS. OSHPD underreported transfusions compared to hospital data. The net effect was a markedly higher true rate of transfusion (40.7% vs. 70.2%).
CONCLUSIONS: These results point out the difficulties in using this administrative data base to describe clinical care for ACS given the variation in clinician recognition of this entity. OSPHD is widely used to inform health care policy in California and contributes to national databases. Our study suggests that using this administrative database to assess clinical care for SCD may lead to inaccurate assumptions about quality of care for SCD patients in California. Future studies on health services in SCD may require a different methodology.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  acute chest; administrative data; sickle cell disease; transfusion

Mesh:

Year:  2013        PMID: 24039121      PMCID: PMC3864696          DOI: 10.1002/pbc.24747

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  17 in total

1.  How to code symptoms and definitive diagnoses.

Authors:  S Prophet
Journal:  J AHIMA       Date:  2000-06

Review 2.  Managing sickle cell disease.

Authors:  Susan Claster; Elliott P Vichinsky
Journal:  BMJ       Date:  2003-11-15

3.  Lack of agreement in pediatric emergency department discharge diagnoses from clinical and administrative data sources.

Authors:  Marc H Gorelick; Stacey Knight; Evaline A Alessandrini; Rachel M Stanley; James M Chamberlain; Nathan Kuppermann; Elizabeth R Alpern
Journal:  Acad Emerg Med       Date:  2007-06-06       Impact factor: 3.451

4.  Validating billing data for RBC transfusions: a brief report.

Authors:  J B Segal; P M Ness; N R Powe
Journal:  Transfusion       Date:  2001-04       Impact factor: 3.157

5.  Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance.

Authors:  Samir K Ballas; Margaret Lusardi
Journal:  Am J Hematol       Date:  2005-05       Impact factor: 10.047

Review 6.  Assessing quality using administrative data.

Authors:  L I Iezzoni
Journal:  Ann Intern Med       Date:  1997-10-15       Impact factor: 25.391

7.  Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group.

Authors:  E P Vichinsky; L D Neumayr; A N Earles; R Williams; E T Lennette; D Dean; B Nickerson; E Orringer; V McKie; R Bellevue; C Daeschner; E A Manci
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

8.  Declining stroke rates in Californian children with sickle cell disease.

Authors:  Heather J Fullerton; Robert J Adams; Shoujun Zhao; S Claiborne Johnston
Journal:  Blood       Date:  2004-03-30       Impact factor: 22.113

9.  Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease.

Authors:  John J Strouse; Clifford M Takemoto; Jeffrey R Keefer; Gregory J Kato; James F Casella
Journal:  Pediatr Blood Cancer       Date:  2008-05       Impact factor: 3.167

10.  Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London.

Authors:  Paul Telfer; Pietro Coen; Subarna Chakravorty; Olu Wilkey; Jane Evans; Heather Newell; Beverley Smalling; Roger Amos; Adrian Stephens; David Rogers; Fenella Kirkham
Journal:  Haematologica       Date:  2007-07       Impact factor: 9.941

View more
  4 in total

1.  A National Measurement Framework to Assess and Improve Sickle Cell Care in 4 US Regions.

Authors:  Elissa Z Faro; Lisa Shook; Marsha J Treadwell; Allison A King; Lauren N Whiteman; E Donnell Ivy; Mary Hulihan; Patricia L Kavanagh; Sabrina Selk; Suzette Oyeku; Scott D Berns
Journal:  Public Health Rep       Date:  2020-07-08       Impact factor: 2.792

2.  Emergency department utilization by Californians with sickle cell disease, 2005-2014.

Authors:  Susan T Paulukonis; Lisa B Feuchtbaum; Thomas D Coates; Lynne D Neumayr; Marsha J Treadwell; Elliott P Vichinsky; Mary M Hulihan
Journal:  Pediatr Blood Cancer       Date:  2016-12-21       Impact factor: 3.167

3.  Comparison of administrative/billing data to expected protocol-mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group.

Authors:  Tamara P Miller; Andrea B Troxel; Yimei Li; Yuan-Shung Huang; Todd A Alonzo; Robert B Gerbing; Matt Hall; Kari Torp; Brian T Fisher; Rochelle Bagatell; Alix E Seif; Lillian Sung; Alan Gamis; David Rubin; Selina Luger; Richard Aplenc
Journal:  Pediatr Blood Cancer       Date:  2015-03-11       Impact factor: 3.167

4.  Association of Guideline-Adherent Antibiotic Treatment With Readmission of Children With Sickle Cell Disease Hospitalized With Acute Chest Syndrome.

Authors:  David G Bundy; Troy E Richardson; Matthew Hall; Jean L Raphael; David C Brousseau; Staci D Arnold; Ram V Kalpatthi; Angela M Ellison; Suzette O Oyeku; Samir S Shah
Journal:  JAMA Pediatr       Date:  2017-11-01       Impact factor: 16.193

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.